Ultragenyx Pharmaceutical Inc. (RARE) rose 8.9% or 4.75 to $58.14. It is nearly 1.64 million shares traded, which is 363.57% compare to the average total volume 450551. The market cap of RARE is $2.48 billion. The year to date change is 8.32%. The 52 week price range is from $43.14 to $91.34. Price of RARE have changed 16.55% during last week. It have changed 11.16% over last month, 5.93% over last 3 months, -25.42% over last 6 months and -21.93% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for RARE is 47.75. It is -17.87% below current price. The 200-day Moving Averages for RARE is 55.64. It is -4.30% below current price. The 52-week High is 91.34. It is 57.10% from the current price. The 52-week Low is 43.14. It is -25.80% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of RARE is 10.76 on 2017-12-29. Short % to float is 13.18%. There are some statistics of RARE. It is has market cap $2.48 billion. The share outstanding is 42.59 million. The average volume is 450551. The revenue is 203000. The percent of top 15 Institution holding is 91.20%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of RARE is -71.02%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of RARE is -61.40%.